Seamus Mulligan - Mar 4, 2023 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role
Director
Signature
By: /s/Adam Guttmann, as attorney in fact For: Seamus Mulligan
Stock symbol
JAZZ
Transactions as of
Mar 4, 2023
Transactions value $
$266,085
Form type
4
Date filed
3/7/2023, 07:30 PM
Previous filing
Aug 9, 2022
Next filing
Jun 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Options Exercise $266K +4.5K +0.39% $59.13 1.16M Mar 4, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JAZZ Non-Qualified Stock Option (right to buy) Options Exercise $0 -4.5K -100% $0.00* 0 Mar 4, 2023 Ordinary Shares 4.5K $59.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Option Plan and vested in 12 monthly installments over one year from the grant date, March 5, 2013.